Highline Wealth Partners »

Zentalis Pharmaceuticals shares owned by Highline Wealth Partners

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Highline Wealth Partners from 13F filings

Historical chart of Highline Wealth Partners investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Highline Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Highline Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.8k 5.0k 1.35
2025-09-30 $18k 12k 1.51
2025-06-30 $8.1k 7.0k 1.16

More positions owned by Highline Wealth Partners

JPMorgan Ultra-Short Income ETF Etf (JPST)
Nvidia Corporation Stock (NVDA)
Janus Henderson AAA CLO ETF Etf (JAAA)
Vanguard S&P 500 ETF Etf (VOO)
Apple Inc Com/Inv Stock (AAPL)
iShares Core MSCI EAFE ETF Etf (IEFA)
Microsoft Corp Stock (MSFT)
Invesco Nasdaq 100 Etf Etf (QQQM)
Schwab Fundamental U.s. Large Company Etf Etf (FNDX)
Vanguard Russell 1000 Value ETF Etf (VONV)
Amazon Stock (AMZN)
iShares 5-10 Year Investment Grade Corporate Bond ETF Etf (IGIB)
Meta Platforms Inc Cl A Stock (META)
Tesla Stock (TSLA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)

View all positions for Highline Wealth Partners

Top funds holding Zentalis Pharmaceuticals

5AM Venture Management
Renaissance Technologies
Vanguard Group
Acadian Asset Management
Citadel Advisors
Two Sigma Advisers
D. E. Shaw & Co
Opaleye Management
Two Sigma Investments
Decheng Capital
BlackRock
Balyasny Asset Management
GSA Capital Partners
Tybourne Capital Management
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals